Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Finding discriminating structural features by reassembling common building blocks.

Kevin P Cross1, Glenn Myatt, Chihae Yang

  • 1Leadscope, Inc., 1245 Kinnear Road, Columbus, Ohio 43212, USA.

Journal of Medicinal Chemistry
|October 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the chemical space of pharmaceutical extractables and leachables.

Regulatory toxicology and pharmacology : RTP·2026
Same author

QSAR in the AI Era: Reflections for Advancing Chemical Safety Assessment.

Chemical research in toxicology·2026
Same author

Risk (Re)assessment of N-Methyl-N-nitrosophenethylamine for use in computing risk levels of N-Nitrosamine drug substance related impurities.

Regulatory toxicology and pharmacology : RTP·2025
Same author

Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymes.

Frontiers in pharmacology·2025
Same author

Quantitative Structure-Activity Relationship Models to Predict Cardiac Adverse Effects.

Chemical research in toxicology·2024
Same author

<i>In Silico</i> Assessment of Biomolecule Reactivity with Leachables.

PDA journal of pharmaceutical science and technology·2024
Same journal

A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

Journal of medicinal chemistry·2026
Same journal

Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

Journal of medicinal chemistry·2026
Same journal

GID4-Recruiting PROTACs for BRD4 Degradation Overcome Resistance Driven by CRBN and VHL Deficiency.

Journal of medicinal chemistry·2026
Same journal

Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer.

Journal of medicinal chemistry·2026
Same journal

Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R.

Journal of medicinal chemistry·2026
Same journal

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
See all related articles

We developed a new algorithm to identify key molecular substructures for drug discovery. This method aids in understanding biological activity and classifying chemical compounds, accelerating the development of new therapeutics.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Cheminformatics

Background:

  • Identifying discriminating substructures is crucial for drug discovery and development.
  • Existing methods may lack the flexibility to address diverse objectives in chemical analysis.

Purpose of the Study:

  • To present a novel algorithm for constructing discriminating substructures from common medicinal chemistry building blocks.
  • To demonstrate the algorithm's versatility in addressing multiple analytical goals.

Main Methods:

  • The algorithm reassembles common chemical building blocks into substructures.
  • Parametrization allows for different objectives: biological activity discrimination, scaffold generation, cluster signature construction, and class characterization.
  • Application to a dataset of 118 compounds with in vitro inhibition data against protein tyrosine phosphatase 1B (PTP-1B).

Related Experiment Videos

Main Results:

  • The algorithm successfully generated substructures for various analytical purposes.
  • Demonstrated utility in analyzing structure-activity relationships and compound classification.
  • Identified characteristic substructures within the PTP-1B inhibitor dataset.

Conclusions:

  • The presented method offers a flexible and powerful approach for substructure analysis in medicinal chemistry.
  • This tool can enhance the understanding of structure-activity relationships and facilitate drug design.
  • The algorithm's adaptability makes it valuable for diverse cheminformatics tasks.